CoChat

Treatment and Outcomes of Precocious Puberty: An Update

Fuqua, John S. · 2013 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Precocious puberty is a common problem affecting up to 29 per 100,000 girls per year. The earliest identified neuroendocrine change in early puberty thus far is increased kisspeptin secretion from the arcuate nucleus and the anteroventral paraventricular nucleus of the hypothalamus. The regulation of kisspeptin secretion is not well understood, but neurokinin B and dynorphin provide autocrine regulation. The etiologies of precocious puberty may be subdivided into GnRH-dependent and GnRH-independent causes. GnRH-dependent precocious puberty, often called central precocious puberty (CPP), is usually treated with GnRH analogs. Newer developments in the treatment of CPP include expanded data on the safety and efficacy of the subdermal histrelin implant, which is useful for long-term treatment, although removal may be difficult in some cases. Preliminary data suggest that the implant may be left in place for up to 2 years without loss of biochemical suppression. In the last 2 years, more data have been published concerning extended-release leuprolide acetate injections that indicate that the 11.25-mg dose may not provide full biochemical suppression but may clinically suppress signs of puberty, including the accelerated growth velocity and advanced skeletal maturation seen in CPP. Treatment options for familial male-limited precocious puberty and McCune-Albright syndrome are expanding as well, although data are preliminary. Long-term outcome studies of CPP indicate overall good menstrual and reproductive function, but the prevalence of polycystic ovary syndrome may be higher than in the general population. Remarkably few studies have evaluated the behavioral and psychological outcomes of precocious puberty, in contrast to early normal maturation. Additional outcome studies of endocrine, metabolic, and psychological effects of CPP are clearly needed.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2013-1024

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 61 references

Cited by

See all 260

Metadata

Authors
Fuqua, J. S.
Affiliations
Indiana University Indianapolis (US)
Corresponding author
Fuqua, John S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-06-01
Volume
98
Issue
6
Pages
2198-2207
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2170468182
Cited by
260
References
61
Citations by year
2026: 10 · 2025: 17 · 2024: 20 · 2023: 27 · 2022: 17 · 2021: 23 · 2020: 21 · 2019: 23 · 2018: 12 · 2017: 22 · 2016: 13 · 2015: 31 · 2014: 20 · 2013: 4
FWCI
3.68
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
precocious puberty, central precocious puberty, GnRH analogues, kisspeptin, neurokinin B, dynorphin, leuprolide, familial male-limited precocious puberty, McCune-Albright syndrome, polycystic ovary syndrome, skeletal maturation, psychological outcomes, treatment outcomes
MeSH terms
Delayed-Action Preparations, Drug Implants, Female, Humans, Gonadotropin-Releasing Hormone, Male, Puberty, Puberty, Precocious, Leuprolide, Treatment Outcome, Kisspeptins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment and Outcomes of Precocious Puberty: An Update. https://app.cochat.ai/papers/10.1210/jc.2013-1024
The paper
Fuqua, J. S. (2013). Treatment and Outcomes of Precocious Puberty: An Update. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-1024

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.